Objective: The effect of aortic arch involvement in patients with uncomplicated acute type B aortic dissection (ATBAD) is unknown. Some studies have noted increased complications, need for early intervention, and mortality with arch involvement. This study aimed to determine the impact of arch involvement on outcomes in ATBAD.
represents a significant burden to society from both a quality and financial perspective, costing as much as 2.3% of the annual Medicare budget. We examined the variation in Medicare payments associated with lower extremity bypass (LEB) surgery, focusing on total payments, including hospital payments, outlier payments, readmission payments, and postdischarge care.
Methods: All patients undergoing LEB between 2009 and 2012 were identified in the MedPar database. Patients with concomitant suprainguinal surgery, major amputation, or atheroembolism were excluded. Risk-and reliability-adjusted mortality rates were generated for all hospitals. Hospital payment data were aggregated into diagnosis-related group (DRG) payments, outlier payments, physician payments, readmission payments, and postdischarge payments. Hospital quintiles of cost were generated, and variation in component payments was examined.
Results [IQR] , $10,851-$24,581) were similar to those for combined LEB and endarterectomy ($15,796; IQR, $11,595-$25,530); however, LEB with minor amputation was significantly more costly ($33,807; IQR, $22,458-$53,615; P < .001). The Table shows the proportion of payments attributable to DRG, outlier, readmission, physician, and postdischarge payments across hospital quintiles of total Medicare payments. There was wide variation in the distribution of payments. High-payment hospitals appear to be more likely to treat a higher proportion of patients for tissue loss compared with low-payment hospitals.
Conclusions: Medicare payments for LEB vary significantly across patients and hospitals. A significant source of variation appears to be the indication for treatment. Patients suffering from tissue loss requiring amputation have significantly higher payments. Hospital variation in Medicare payments can be attributed to multiple factors, including DRG, physician services, readmission, and postdischarge payments. Efforts to address PAD quality and cost will need to account for the heterogeneity of this population and the high cost of tissue loss.
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